FDA approved an Investigational Device Exemption application to initiate a multi-center study for the treatment of recurrent cutaneous squamous cell carcinoma in immunocompromised patients using the Alpha DaRT.
FDA granted 510(k) clearance to GE HealthCare’s MIM Software tool to calculate the absorbed dose of radionuclides using a Monte Carlo method.
AML Express, a next-generation sequencing assay designed to provide rapid, comprehensive genetic profiling for patients with acute myeloid leukemia, was announced by NeoGenomics Inc.
PatientPoint, a digital health company, launched an interactive, in-office digital hub that delivers specialty-specific, customizable content and practice tools for clinicians, and allows for streamlined workflows, and enhanced collaboration across care teams.
Myriad Genetics Inc. and Ultima Genomics Inc. join to explore Ultima’s UG 100 sequencing platform and its ppmSeq technology to advance Myriad’s ability to offer groundbreaking clinical tests. Myriad has purchased a new UG 100 that will soon join other leading sequencing platforms in its Lab of the Future facility in South San Francisco.
The FDA Oncologic Drugs Advisory Committee on Sept. 26 voted that PD-L1 inhibitors should not be indicated as a first-line treatment for patients with PD-L1-negative gastric/gastroesophageal junction adenocarcinoma and esophageal squamous cell carcinoma.
Having had the honor and pleasure to lead an NCI-designated cancer center for several years, I would like to share my thoughts on this small yet unique set of institutes and their value to NCI and the nation.
On Nov. 24, 2003, an article in The Boston Globe told the story of a patient’s remarkable response to gefitinib, a drug that had recently been approved by FDA.
Kevin Holcomb will join Northwell Health as chair of the Department of Obstetrics and Gynecology at North Shore University Hospital in Manhasset, Long Island Jewish Medical Center in New Hyde Park, and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale.
Meagan O. O’Neill was named executive director of the Association of Cancer Care Centers. O’Neill will serve as the third executive director and the first woman in the role.
